EndoTheia Receives Approval for First-In-Human

August 5th, 2021

EndoTheia received approval to conduct a small-scale first-in-human (FIH) study to assess the safety of our endoscopic technology in support of our upcoming regulatory submission. Subject recruitment will commence in Q4 of 2022.

EndoTheia Receives Match Funding from LaunchTN

September 31, 2021

EndoTheia is awarded $300,000 in SBIR match funding from the state of TN to forge in-state manufacturing partnerships, finance laboratory testing efforts for upcoming regulatory submissions, and secure vital intellectual property. 

EndoTheia Receives Direct-To-Phase II SBIR Grant

August  31, 2021

EndoTheia is awarded a $1.4m SBIR Direct-To-Phase II Grant from the National Institute of Biomedical Imaging and Bioinformatics (NIBIB) to explore the use of EndoTheia technology in the minimally-invasive treatment of renal calculi. 

EndoTheia Receives Direct-To-Phase II SBIR Grant

August 13, 2021

EndoTheia is awarded a $1.4m SBIR Direct-To-Phase II Grant from the National Institute of Deafness and Communication Disorders (NIDCD) to explore the use of EndoTheia technology in the nonsurgical surveillance and diagnosis of middle ear disease. 

EndoTheia Begins Formal Operations at New HQ

September 28, 2020

After incubating within Vanderbilt University since 2018, EndoTheia begins formal operations and moves into its first engineering offices and engineering laboratory, located in the bustling Midtown district of downtown Nashville, to begin developing next-generation endoscopic devices.

EndoTheia Receives Direct-To-Phase II SBIR Grant

June 16, 2020

EndoTheia is awarded a $1.2m SBIR Direct-To-Phase II Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to further study the use of EndoTheia's technology in the treatment of biliary disease. 

EndoTheia Receives Phase I STTR Grant for ESD

August 1st, 2019

EndoTheia is awarded a $225k STTR Phase I Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to investigate the use of EndoTheia's technology in the endoscopic treatment of early-stage colorectal tumors.

EndoTheia is Formally Incorporated

August 15th, 2018

EndoTheia, Inc. is formally incorporated to commercialize an innovative flexible medical device technology originally developed at Vanderbilt University.